Cargando…

Therapeutic plasma exchange in multiple sclerosis patients with an aggressive relapse: an observational analysis in a high-volume center

An evidence-based treatment for a Multiple Sclerosis (MS) relapse is an intravenous administration of 3–5 g of Methylprednisolone. In case of insufficient effect or corticosteroids intolerance, the therapeutic plasma exchange (TPE) is indicated. To assess the clinical effect of TPE in treatment of r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bunganic, R., Blahutova, S., Revendova, K., Zapletalova, O., Hradilek, P., Hrdlickova, R., Ganesh, A., Cermakova, Z., Bar, M., Volny, O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626567/ https://www.ncbi.nlm.nih.gov/pubmed/36319704 http://dx.doi.org/10.1038/s41598-022-23356-w

Ejemplares similares

Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases
por: Kušnierová, Pavlína, et al.
Publicado: (2020)

Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study
por: Tabrizi, Nasim, et al.
Publicado: (2012)

Comparing Plasma Exchange to Escalated Methyl Prednisolone in Refractory Multiple Sclerosis Relapses
por: Pfeuffer, Steffen, et al.
Publicado: (2019)

Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study
por: Blechinger, Stephan, et al.
Publicado: (2021)

Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
por: Kušnierová, Pavlína, et al.
Publicado: (2019)

Detection of oligoclonal IgG kappa and IgG lambda bands in cerebrospinal fluid and serum with Hevylite™ antibodies. comparison with the free light chain oligoclonal pattern
por: Zeman, David, et al.
Publicado: (2012)

Demographic and disease‐related factors impact on cerebrospinal fluid neurofilament light chain levels in multiple sclerosis
por: Zondra Revendova, Kamila, et al.
Publicado: (2022)

Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry
por: Vališ, Martin, et al.
Publicado: (2022)

Relaxation-Compensated Chemical Exchange Saturation Transfer MRI in the Brain at 7T: Application in Relapsing-Remitting Multiple Sclerosis
por: O'Grady, Kristin P., et al.
Publicado: (2022)

Efficacy of cascade plasmapheresis in comparison with conventional therapeutic plasma exchange for relapsed atypical hemolytic uremic syndrome: A case report
por: Vaidya, Ashwinkumar, et al.
Publicado: (2022)

Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations
por: Then Bergh, Florian, et al.
Publicado: (2006)

Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting
por: Zeman, David, et al.
Publicado: (2016)

The Effect of Glatiramer Acetate on Spinal Cord Volume in Relapsing‐Remitting Multiple Sclerosis
por: Singhal, Tarun, et al.
Publicado: (2016)

Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients—A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness
por: Ehler, Johannes, et al.
Publicado: (2017)

Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: A randomised, parallel-group, controlled trial
por: Dorst, Johannes, et al.
Publicado: (2019)

Association of iron rim lesions with brain and cervical cord volume in relapsing multiple sclerosis
por: Weber, Claudia E., et al.
Publicado: (2021)

Cost of managing an episode of relapse in multiple sclerosis in the United States
por: O'Brien, Judith A, et al.
Publicado: (2003)

Therapeutic Plasma Exchange in Multiple Sclerosis Patients with Abolished Interferon-beta Bioavailability
por: Giedraitiene, Natasa, et al.
Publicado: (2015)

Therapeutic plasma exchange for the treatment of systemic sclerosis: A comprehensive review and analysis
por: Harris, Edward S, et al.
Publicado: (2018)

Quantitative Determination of Regional Lesion Volume and Distribution in Children and Adults with Relapsing-Remitting Multiple Sclerosis
por: Ghassemi, Rezwan, et al.
Publicado: (2014)

Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis
por: Barkhof, Frederik, et al.
Publicado: (2019)

Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis
por: Cree, Bruce AC, et al.
Publicado: (2020)

Primary mediastinal seminoma; resistance and relapse: An aggressive entity
por: Nachankar, Ankita, et al.
Publicado: (2013)

Aggressive behavior in patients hospitalised for a psychotic relapse
por: Bouguerra, I., et al.
Publicado: (2023)

Aggressive multiple sclerosis (2): Treatment
por: Arrambide, Georgina, et al.
Publicado: (2020)

Remissions and Relapses in Insular Sclerosis
Publicado: (1904)

The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis
por: Dupuy, Sheena L., et al.
Publicado: (2016)

Development of Cortical Lesion Volumes on Double Inversion Recovery MRI in Patients With Relapse-Onset Multiple Sclerosis
por: Faizy, Tobias D., et al.
Publicado: (2019)

Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging
por: Kolind, Shannon, et al.
Publicado: (2023)

Plasma exchange with albumin replacement and disease progression in amyotrophic lateral sclerosis: a pilot study
por: Povedano, Mónica, et al.
Publicado: (2021)

Severe Leptospirosis with Multiple Organ Failure Successfully Treated by Plasma Exchange and High-Volume Hemofiltration
por: Bourquin, Vincent, et al.
Publicado: (2011)

Fulminant hepatitis A complicated by Takotsubo syndrome successfully treated with standard volume plasma exchange
por: Caballol, Berta, et al.
Publicado: (2019)

Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study
por: Bar-Or, Amit, et al.
Publicado: (2018)

Discolouration of plasma in therapeutic plasma exchange
por: Bala Kumar, SS Deepak, et al.
Publicado: (2021)

The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
por: Hermann, Robert, et al.
Publicado: (2018)

Nutritional Exchanges Within Tumor Microenvironment: Impact for Cancer Aggressiveness
por: Comito, Giuseppina, et al.
Publicado: (2020)

Genetic background and evolution of relapses in aggressive B-cell lymphomas
por: Juskevicius, Darius, et al.
Publicado: (2017)

Very Late Local Relapse of Ewing's Sarcoma of the Head and Neck treated with Aggressive Multimodal Therapy
por: Thariat, J., et al.
Publicado: (2008)

Cytotoxic B Cells in Relapsing-Remitting Multiple Sclerosis Patients
por: Boldrini, Vinícius O., et al.
Publicado: (2022)

Lower number of plasma exchange sessions and glomerular filtration rate decline are associated with second relapses in patients with myasthenia gravis
por: Premuzic, Vedran, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0v0cfm9b3pfd03pq5t1d6e93ad